Results 141 to 150 of about 214,432 (171)

Association of anti-tuberculosis drug concentrations in hair and treatment outcomes in MDR- and XDR-TB. [PDF]

ERJ Open Res, 2019
Metcalfe J, Bacchetti P, Gerona R, Esmail A, Dheda K, Gandhi M.   +5 more
europepmc   +1 more source

Predictive factors for unfavourable treatment in MDR-TB and XDR-TB patients in Rio de Janeiro State, Brazil, 2000-2016. [PDF]

PLoS One, 2019
Bhering M, Duarte R, Kritski A.
europepmc   +1 more source

Global Burden of Tuberculosis and Drug-Resistant Subtypes Among Women of Childbearing Age from 1990 to 2021, with Projections to 2030. [PDF]

Int J Womens Health
Chen J, Peng X, Zheng Y, Chen R.
europepmc   +1 more source

Drug-resistance profiles, population structure, genomic clustering, and temporal trends in drug resistance among <i>Mycobacterium tuberculosis</i> complex isolates in Ukraine, 2019-2023: a multicentre cohort study. [PDF]

Lancet Reg Health Eur
Butov D, Butova T, Miasoiedov V, Feshchenko Y, Nakonechna O, Kuzhko M, Rosenthal A, Grinev A, Hoppes D, Kilmnick J, Levandovska D, Hryhorieva A, Vekshyn V, Abramova L, Niemann S, Dreyer V, Ukrainian TB Portal Collaborators.   +16 more
europepmc   +1 more source

Whole-genome sequencing guides the successful treatment of extensively drug-resistant TB. [PDF]

IJTLD Open
Makamure B, Phelan J, Bandason T, Chipinduro M, Mutsvangwa J, Metcalfe JZ, Fernandez FT, Manasa J.   +7 more
europepmc   +1 more source

When are Uncontrolled Trials in TB Scientifically and Ethically Justified: Borrowing Wisdom From Early AIDS Clinical Trials. [PDF]

Clin Infect Dis
McKenna L, Frick M, Alarcón-Guizado VA, Davies GR, Furin JJ, Guglielmetti L, Heinrich N, Low M, Mahmoud M, Mave V, Ndjeka N, Phillips PPJ, Schumacher S, Harrington M, Mitnick CD.   +14 more
europepmc   +1 more source

Risk factors and prediction modeling for drug-resistant tuberculosis in Shenzhen: a 9-year retrospective study. [PDF]

Front Public Health
Wang J, Chen M, Zha X, Ding F, Zhang H, Lu SH, Liu X.   +6 more
europepmc   +1 more source

Genomic insights into low-level rifampicin resistance mediated by borderline <i>rpoB</i> mutations in <i>Mycobacterium tuberculosis</i>: prevalence and phylogeny in Northeast China. [PDF]

Microbiol Spectr
Li L, Zhang M, Su L, Qin X, Liu H, Zhang X, Liu K, Sun X, Yan F.   +8 more
europepmc   +1 more source